Zobrazeno 1 - 10
of 12
pro vyhledávání: '"NCB de Jager"'
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/1965d1889ddf4cbeb8a1d66664e6a252
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
BMJ open, 12(2):e049493. BMJ Publishing Group
BMJ Open, 12(2):e049493. BMJ Publishing Group
BMJ open, 12(2):e049493. BMJ Publishing Group
BMJ Open, 12(2):e049493. BMJ Publishing Group
IntroductionVon Willebrand disease (VWD) is a bleeding disorder, caused by a deficiency or defect of von Willebrand factor (VWF). In case of medical procedures or bleeding, patients are treated with desmopressin and/or VWF-containing concentrates to
Autor:
Heijdra JM; Department of Paediatric Haematology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, The Netherlands., Cloesmeijer ME; Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Jager NCB; Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Leebeek FWG; Department of Haematology, Erasmus MC, Erasmus University Medical Centre Rotterdam, The Netherlands., Kruip MHJA; Department of Haematology, Erasmus MC, Erasmus University Medical Centre Rotterdam, The Netherlands., Cnossen MH; Department of Paediatric Haematology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, The Netherlands., Mathôt RAA; Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Sep; Vol. 28 (5), pp. 814-821. Date of Electronic Publication: 2022 May 08.
Autor:
Heijdra JM; Department of Pediatric Hematology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands., Al Arashi W; Department of Pediatric Hematology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands., de Jager NCB; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Cloesmeijer ME; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Bukkems LH; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Zwaan CM; Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands., Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Mathôt RAA; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Cnossen MH; Department of Pediatric Hematology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands m.cnossen@erasmusmc.nl.
Publikováno v:
BMJ open [BMJ Open] 2022 Feb 15; Vol. 12 (2), pp. e049493. Date of Electronic Publication: 2022 Feb 15.
Autor:
Bukkems LH; Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands., Heijdra JM; Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, The Netherlands., de Jager NCB; Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands., Hazendonk HCAM; Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, The Netherlands., Fijnvandraat K; Pediatric Hematology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Meijer K; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Eikenboom JCJ; Division of Thrombosis and Hemostasis, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands., Laros-van Gorkom BAP; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands; and., Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Cnossen MH; Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, The Netherlands., Mathôt RAA; Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2021 Mar 09; Vol. 5 (5), pp. 1513-1522.
Autor:
de Jager NCB; Clinical Pharmacology and Hospital Pharmacy-Amsterdam UMC, University of Amsterdam, Amsterdam., Heijdra JM; Department of Paediatric Haematology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam., Pistorius M; Clinical Pharmacology and Hospital Pharmacy-Amsterdam UMC, University of Amsterdam, Amsterdam., Kruip MJHA; Department of Haematology, Erasmus University Medical Centre, Rotterdam., Leebeek FWG; Department of Haematology, Erasmus University Medical Centre, Rotterdam., Cnossen MH; Department of Paediatric Haematology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam; and., Mathôt RAA; Clinical Pharmacology and Hospital Pharmacy-Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2020 Dec; Vol. 42 (6), pp. 880-885.
Autor:
de Jager NCB; Hospital Pharmacy-Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Heijdra JM; Department of Paediatric Haematology, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands., Kieboom Q; Department of Paediatric Haematology, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands., Kruip MJHA; Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Leebeek FWG; Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Cnossen MH; Department of Paediatric Haematology, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands., Mathôt RAA; Hospital Pharmacy-Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2020 Oct; Vol. 120 (10), pp. 1407-1416. Date of Electronic Publication: 2020 Aug 03.
Autor:
de Jager NCB; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bukkems LH; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Heijdra JM; Department of Paediatric Hematology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands., Hazendonk CHCAM; Department of Paediatric Hematology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands., Fijnvandraat K; Amsterdam UMC, Emma Children's Hospital, Pediatric Hematology, University of Amsterdam, Amsterdam, Netherlands., Meijer K; Department of Haematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Eikenboom J; Department of Internal Medicine, Division of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands., Laros-van Gorkom BAP; Department of Haematology, Radboud University Medical Center, Nijmegen, The Netherlands., Leebeek FWG; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Cnossen MH; Department of Paediatric Hematology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands., Mathôt RAA; Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Feb; Vol. 18 (2), pp. 295-305. Date of Electronic Publication: 2019 Oct 21.
Autor:
van Dijkman SC; Division of Pharmacology, LACDR, Einsteinweg 55, Leiden, The Netherlands., de Jager NCB; Division of Pharmacology, LACDR, Einsteinweg 55, Leiden, The Netherlands., Rauwé WM; Division of Pharmacology, LACDR, Einsteinweg 55, Leiden, The Netherlands., Danhof M; Division of Pharmacology, LACDR, Einsteinweg 55, Leiden, The Netherlands., Della Pasqua O; Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Uxbridge, UK. o.dellapasqua@ucl.ac.uk.; Clinical Pharmacology and Therapeutics Group, UCL, BMA House, Tavistock Square, London, UK. o.dellapasqua@ucl.ac.uk.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2018 Nov; Vol. 57 (11), pp. 1473-1475.
Autor:
van Dijkman SC; Division of Pharmacology, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC, Leiden, The Netherlands., de Jager NCB; Division of Pharmacology, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC, Leiden, The Netherlands., Rauwé WM; Division of Pharmacology, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC, Leiden, The Netherlands., Danhof M; Division of Pharmacology, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC, Leiden, The Netherlands., Della Pasqua O; Division of Pharmacology, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC, Leiden, The Netherlands. oscar.e.della-pasqua@gsk.com.; Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Uxbridge, UB11 1BT, UK. oscar.e.della-pasqua@gsk.com.; Clinical Pharmacology and Therapeutics Group, University College London, BMA House, Tavistock Square, London, WC1H 9JP, UK. oscar.e.della-pasqua@gsk.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2018 Aug; Vol. 57 (8), pp. 1055-1056.